Protein Sensitivity to Tungsten - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Protein Sensitivity to Tungsten
The authors investigate the effect of low pH and ionic strength on aggregation using turbidity measurements and size-exclusion–high-performance liquid chromatography.


Pharmaceutical Technology
pp. s28-s32

Results and discussion

Protein aggregation in the presence of tungstate was observed from pH 4 to 5.5, but not at pH 6 or 7. Aggregation was blocked by increasing the ionic strength with NaCl. The concentration of salt required to prevent precipitation was protein-dependent, but also varied with both pH and tungstate concentration. Once formed, precipitates could be resolubilized by raising the pH to 7. Not all proteins precipitated in the presence of tungstate, including those with low isoelectric points. Unlike glass prefilled syringes, which contained measurable amounts of tungsten and silicone, syringes made of plastic were both tungsten and silicone-free.


Figure 1: Effect of pH on the precipitation of bIgG by tungstate. Soluble monomer was quanititated by size-exclusion chromatography. (ALL FIGURES ARE COURTESY OF THE AUTHORS)
Aggregation by tungstate requires acidic pH. Assays were carried out with bovine IgG (bIgG) over the pH range 4–7 at 1, 10, and 100 ppm tungstate. Figure 1 shows that the bIgG monomer is quantitatively precipitated by 10 and 100 ppm tungstate at pH 4.0–5.5, but is not affected at pH 6.0 or 7.0. The data also show that lower tungstate (1 ppm) is not as effective as higher concentrations at precipitating bIgG.


Figure 2: Effect of ionic strength on the precipitation of proteins by tungstate. Soluble protein was quantitated by size-exclusion–high-performance liquid chromatography.
The effect of ionic strength on protein precipitation by tungstate. The effect of ionic strength on the precipitation of proteins by tungstate was investigated as many drug formulations contain salt. Figure 2 shows the effect of ionic strength on the precipitation of solutions of Chymotrypsinogen A (Chy A) and bIgG by tungstate at pH 5.0. The data indicate that 100 mM NaCl was sufficient to completely block the precipitation of ChyA by tungstate. In contrast, more than 500 mM NaCl was required to completely prevent precipitation of bIgG under the same conditions. In addition, higher concentrations of salt were necessary to block aggregation in the presence of 100 ppm tungstate than 10 ppm tungstate, and higher ionic strength was required to block aggregation by tungstate at pH 5.0 than at pH 5.5 (data not shown). These experiments show that the interaction of tungstate with proteins is primarily electrostatic and that the interaction is stronger at lower pH.


Figure 3: Comparison of protein aggregation by size-exclusion–high-performance liquid chromatography (SEC) with turbidity.
Using turbidity to evaluate protein aggregation by tungstate. Measurement of protein turbidity caused by tungstate aggregation provides a rapid alternative to SEC. Turbidity was monitored spectrophotometrically by measuring the change in absorbance at 350 nm, a wavelength at which protein absorbance is negligible. Figure 3 compares data obtained for four proteins using both methods. The concentrations required to precipitate one-half of the protein (IC50s) for both methods are 10–20 ppm tungstate. An assay based on turbidity could also be performed in a microplate format which would increase throughput and reduce sample handling.


Figure 4: Effect of pH on the precipitation of ovalbumin and lysozyme. Turbidity was measured spectrophotometrically.
Aggregation by tungstate is correlated with protein net charge. The interaction of tungstate polyoxyanions appears to be primarily electrostatic; therefore, proteins with a net positive charge at a particular pH should be precipitable at that pH. When tested at pH 4, there was little difference between the IC50s for bovine serum albumin (BSA, isoelectric point (pI) 4.2–4.9), ovalbumin (pI 4.5–4.7), and the basic proteins of ChyA (pI 8.8–9.6) and lysozyme (pI 10.5–11) (see Figure 4). These four proteins all differ in mass, isoelectric point, net charge, and total number of positive charges (see Table I). However, pepsin, which has a pI below 3 and a net negative charge at pH 4, was not precipitated by tungstate even at 1000 ppm (data not shown). This result is consistent with the proposal that the net charge on a protein is a key determinant of precipitability.

Based on these observations, the authors tested whether the pH range over which a protein would be precipitated by tungstate could be predicted. The pH dependence of ovalbumin (pI 4.5–4.7) was compared with lysozyme (pI 10.5–11.0). Figure 4 shows that lysozyme could be precipitated from pH 4 to 5.5, a range over which it remains positively charged. In contrast, ovalbumin was only precipitable at pH 4 and 4.5, but at pH 5 (slightly above its isoelectric point and close to where it is electroneutral), it was no longer precipitable.


Table II: Reversibility of protein aggregates
The interaction of proteins with tungstate is reversible. To determine whether protein/tungstate precipitates are reversible, a set of precipitates of BSA and bIgG were prepared using pH 5.0 buffer and 100 ppm tungstate, conditions shown to quantitatively precipitate each protein. The precipitates were re-suspended in pH 5.0 or pH 7.0 buffer with or without 0.5 M NaCl. Table II shows that dilution into incubation buffer in the absence of tungstate did not solubilize the precipitates. The addition of 0.5 M NaCl at low pH solubilized about 11% of bIgG. Re-suspension in pH 7.0 buffer solubilized greater than 90% of BSA and ~60% of bIgG. However, inclusion of 0.5 M NaCl in pH 7.0 buffer completely solubilized bIgG.


Table III: Tungsten and silicone content of prefilled syringes
Tungsten- and silicone-free prefilled syringes for sensitive proteins. Unlike staked needle syringes made of glass, manufacture of the specialty plastic syringe system (CZ, Daikyo) does not utilize a tungsten pin to create an opening for inserting the needle. Consequently, this syringe system is expected to be tungsten-free. Analysis showed that the amount of extractable tungsten in the plastic syringes is at the level of the solvent blank whereas the amount of tungsten in syringes made of glass is significant (see Table III).

Silicone is present in glass syringes as a lubricant. However, silicone has been observed to cause changes in native protein structure as well as aggregation (7, 8). Analysis showed that specialty plastic syringes, which do not contain silicone oil as a lubricant, are silicon free (see Table III).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here